{
  "completed": [
    0,
    1,
    2,
    3,
    4,
    5,
    6,
    7,
    8,
    9
  ],
  "results": [
    {
      "example_idx": 0,
      "dataset_id": "1511",
      "question": "What is a lockdown?",
      "ground_truth_answer": "A lockdown is the implementation of strict restrictions and measures to limit people's movement and activities in order to control the spread of infections, such as the one mentioned in the given context.",
      "generated_response": "<think>\nOkay, the user is asking, \"What is a lockdown?\" and the context provided seems to be about estimating infections and the impact of non-lockdown measures. Wait, the titles and passages are a bit repetitive. Let me check again.\n\nThe context has four entries. The first three are titled \"Estimating the number of infections and the impact of non-\" with the passage \"Lockdown\". The fourth title is the same but the passage is \"banned Implemented with lockdown.57 24/3/2020\". Hmm, maybe there's a formatting issue here. The user probably intended to provide a paper or study that discusses lockdowns and their impact on infections. \n\nThe question is straightforward: defining a lockdown. Since the context mentions lockdowns in the context of estimating infections, the answer should relate to public health measures. A lockdown typically refers to strict restrictions on movement and activities to prevent the spread of a disease, like during a pandemic. The context might be from a study that compares lockdowns versus non-lockdown strategies. \n\nI need to make sure the answer is accurate and concise. The user might be looking for a basic definition, possibly in the context of public health policies. The mention of \"non-lockdown\" in the titles suggests that the study is analyzing the effects of implementing or not implementing lockdowns. So the answer should define a lockdown as a public health measure involving restrictions to limit movement and gatherings to control disease spread. Also, since the date is 24/3/2020, which is early in the COVID-19 pandemic, the context is likely related to that. \n\nI should avoid any markdown and keep the answer clear. Let me put it all together.\n</think>\n\nA lockdown is a public health measure implemented to restrict movement and gatherings of people in order to slow the spread of a contagious disease, such as during a pandemic. It typically involves strict limitations on non-essential activities, closure of businesses, schools, and public spaces, and enforcement of stay-at-home orders. The context provided references studies analyzing the impact of lockdowns versus non-lockdown strategies on infection rates, particularly in the context of the COVID-19 pandemic (as indicated by the date 24/3/2020).",
      "retrieved_chunks": [
        "Title: Estimating the number of infections and the impact of non-\nPassage: Lockdown\n\nTitle: Estimating the number of infections and the impact of non-\nPassage: Lockdown\n\nTitle: Estimating the number of infections and the impact of non-\nPassage: Lockdown\n\nTitle: Estimating the number of infections and the impact of non-\nPassage: banned Implemented with lockdown.57 24/3/2020"
      ],
      "computed_relevance": 1.0,
      "computed_utilization": 1.0,
      "computed_completeness": 1.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.2,
      "gt_utilization": 0.2,
      "gt_completeness": 1.0,
      "gt_adherence": 0.0,
      "binary_pred": 1,
      "binary_gt": 0,
      "is_valid": true,
      "is_rate_limited": false,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 1,
      "dataset_id": "1085",
      "question": "What complications are associated with CHIKV?",
      "ground_truth_answer": "Complications associated with CHIKV include respiratory failure, cardiovascular decompensation, meningoencephalitis, severe acute hepatitis, severe cutaneous effects, other central nervous system problems, and kidney failure.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking about the complications associated with CHIKV, which I know stands for Chikungunya virus. Let me look through the provided context to find all the mentioned complications.\n\nFirst, the passage starts by talking about severe CHIKF (Chikungunya Fever) in patients over 65 and those with underlying conditions. Then it mentions that children are another group affected. The complications listed are respiratory failure, cardiovascular decompensation, meningoencephalitis, severe acute hepatitis, severe cutaneous effects, other central nervous system problems, and kidney failure. That's a list from most common to least.\n\nThen there's a part about mothers transmitting the virus perinatally, leading to high morbidity in neonates. The neonates showed symptoms by day 4, and six had meningoencephalitis. Also, there were cases of encephalitis from vertical transmission. Additionally, fetal deaths were mentioned in the La Reunion Island epidemic, though only three cases were reported when mothers were infected long before delivery.\n\nSo compiling all these, the complications include the ones listed in the first part plus neonatal issues like encephalitis and fetal deaths. I need to make sure I include all the complications mentioned in both sections. Let me check again: respiratory failure, cardiovascular decompensation, meningoencephalitis, severe acute hepatitis, severe cutaneous effects, other CNS problems, kidney failure, and then neonatal encephalitis, fetal deaths. Also, the passage mentions \"other central nervous system problems,\" so maybe I should note that meningoencephalitis is part of that category. The answer should list all these complications clearly.\n</think>\n\nThe complications associated with CHIKV (Chikungunya virus) include:  \n1. **Respiratory failure**  \n2. **Cardiovascular decompensation**  \n3. **Meningoencephalitis** (and other central nervous system problems)  \n4. **Severe acute hepatitis**  \n5. **Severe cutaneous effects**  \n6. **Kidney failure**  \n7. **Neonatal complications** (e.g., encephalitis due to vertical transmission from infected mothers, high morbidity in neonates, and fetal deaths in rare cases of maternal infection long before delivery).  \n\nThese complications are observed in severe cases, particularly in vulnerable groups such as the elderly",
      "retrieved_chunks": [
        "Passage: More than 50% of patients who suffer from severe CHIKF are over 65 y old, and more than 33% of them die. Most adults who suffer from severe CHIKF have underlying medical conditions . The other group that is disproportionately affected by severe CHIKV is children. Other complications associated with CHIKV, from most common to least common, include respiratory failure, cardiovascular decompensation, meningoencephalitis, severe acute hepatitis, severe cutaneous effects, other central nervous system problems, and kidney failure .",
        "discovered that mothers could transmit CHIKV to their progeny during the perinatal period , and it is associated with a high degree of morbidity. By mean Day 4 of life, all of the neonates were symptomatic for CHIKV, exhibiting common CHIKF symptoms. Six neonates were confirmed to have contracted CHIKV and developed mengoencephalitis.",
        "Passage: and complications.",
        "Of those mothers who, during the La Reunion Island epidemic, were infected long before delivery, only three fetal deaths were reported .",
        "reported nineteen cases of neonatal infection associated with intrapartum maternal viremia that progressed to develop encephalitis owing to vertical transmission from infected mothers ."
      ],
      "computed_relevance": 0.4,
      "computed_utilization": 0.7,
      "computed_completeness": 1.0,
      "computed_adherence": 0.0,
      "gt_relevance": 0.2,
      "gt_utilization": 0.2,
      "gt_completeness": 1.0,
      "gt_adherence": 1.0,
      "binary_pred": 0,
      "binary_gt": 1,
      "is_valid": true,
      "is_rate_limited": false,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 2,
      "dataset_id": "1248",
      "question": "What does Clade A contain?",
      "ground_truth_answer": "Clade A contains 1,889 viruses from 34 countries collected from 2010 to the present.",
      "generated_response": "<think>\nOkay, let's try to figure out what Clade A contains based on the provided context. The user is asking about Clade A, but looking through the given passages, I don't see any mention of a clade labeled \"A\". The context talks about clades like 1B.1, 1B.2, 1C.2, and mentions clades in general terms. The titles and passages refer to a phylogeny-based nomenclature system for H1 hemagglutinin genes in swine influenza A viruses.\n\nThe first passage mentions that each clade had an APD (Average Pairwise Distance) of more than 7% from other clades and less than 7% within the clade, with some exceptions. The second passage discusses exceptions like 1B.1 and 1B.2, where 1B.1 had too few sequences and 1B.2 represented multiple monophyletic clades that didn't meet criteria for further division. The third passage mentions the 1C.2 clade as an exception. \n\nThe user's question is about Clade A, but none of the provided text refers to Clade A. The clades mentioned are numbered with 1B and 1C, which suggests a hierarchical system. The main clades discussed are part of the 1B lineage, which includes subclades like 1B.1 and 1B.2. However, there's no mention of a clade labeled \"A\". It's possible that the user might have confused the clade numbering or there's a typo. Alternatively, maybe \"Clade A\" is part of a different lineage not discussed in the provided context. \n\nSince the provided information doesn't include any details about Clade A, the answer would have to state that there's no information available on Clade A in the given context. The answer should clarify that the text refers to other clades like 1B.1, 1B.2, and 1C.2, but not Clade A specifically.\n</think>\n\nThe provided context does not mention or describe **Clade A** specifically. The text refers to clades such as **1B.1**, **1B.2**, **1C.2**, and others within the H1 hemagglutinin gene lineage of swine influenza A viruses. However, there is no information about",
      "retrieved_chunks": [
        "Each clade had an APD of \u03fe7% from other clades and an APD of \u03fd7% within the clade, although some minor exceptions were made when all other clade-defining criteria were met and mitigating circumstances supported the exception.",
        "For the most part, each clade had an APD of \u03fe7% from other clades and an APD of \u03fd7% within the clade.",
        "For the most part, each clade had an APD of \u03fe7% from other clades and almost all had an APD of \u03fd7% within the clade. The within-clade exceptions were the 1B.1 and 1B.2 clades . The 1B.1 second-order clade had too few representative sequences to calculate genetic distance, and 1B.2 represented multiple monophyletic clades that individually did not meet our criteria for further division. Similarly, the extensive 1B.1.1 clade did not meet criteria for further splitting.",
        "The one within-clade exception in this lineage was 1C.2 , which had multiple monophyletic\n\nTitle: A Phylogeny-Based Global Nomenclature System and Automated Annotation Tool for H1 Hemagglutinin Genes from Swine Influenza A Viruses\nPassage: The 1B human seasonal lineage within-and between-clade APDs are presented in Table 3 .",
        "The exception to the between-clade threshold was associated with clades\n\nTitle: A Phylogeny-Based Global Nomenclature System and Automated Annotation Tool for H1 Hemagglutinin Genes from Swine Influenza A Viruses\nPassage: were placed into seven clades. The numerically dominant clades reflected intensive surveillance in the United States , investigator sequencing efforts in Canada , and the rapid dissemination of the 2009 H1N1 pandemic virus across global swine populations ."
      ],
      "computed_relevance": 0.6666666666666666,
      "computed_utilization": 0.8888888888888888,
      "computed_completeness": 1.0,
      "computed_adherence": 0.0,
      "gt_relevance": 1.0,
      "gt_utilization": 0.041666666666666664,
      "gt_completeness": 0.041666666666666664,
      "gt_adherence": 1.0,
      "binary_pred": 0,
      "binary_gt": 1,
      "is_valid": true,
      "is_rate_limited": false,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 3,
      "dataset_id": "1696",
      "question": "How do the S1 subunits compare with that of SARS-likeCOV and human SARS-COV?",
      "ground_truth_answer": "The S1 subunit of 2019-nCoV shares around 70% identity with those of two bat SARS-like CoVs and human SARS-CoV.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking how the S1 subunits of 2019-nCoV compare to those of SARS-like CoVs and human SARS-CoV. First, I need to recall what the context says about the S1 subunit. Wait, the context mentions the S2 subunit being highly conserved with 99% identity across 2019-nCoV, bat SARS-like CoVs, and human SARS-CoV. But the question is about the S1 subunit.\n\nLooking back at the context, there's a part about the Spike's receptor binding domain (which is part of the S1 subunit, I think). It says that the external subdomain of the Spike's receptor binding domain in 2019-nCoV shares only 40% amino acid identity with other SARS-related coronaviruses. Also, unlike 2019-nCoV and human SARS-CoV, most bat SARSr-CoVs have two stretches of deletions in the spike receptor binding domain compared to human SARS-CoV. \n\nAdditionally, the context mentions structures like SL1 to SL8. The S5 part in 2019-nCoV is inside orf1a/b similar to SARS-CoV, but in bat ZC45 it's not. Also, 2019-nCoV shares SL6, SL7, SL8 with SARS-CoV and has an additional one. But I'm not sure if these structures are part of S1 or S2. \n\nSince the S1 subunit is involved in receptor binding (the RBD is part of S1), the 40% identity in the RBD suggests that the S1 subunit of 2019-nCoV is less conserved compared to SARS-like CoVs. Also, the deletions in bat SARSr-CoVs in the RBD compared to human SARS-CoV imply that the S1 subunit in bats has differences there. However, the question is about 2019-nCoV's S1 compared to SARS-like and human SARS-CoV. \n\nSo putting it together: The S1 subunit's receptor binding domain in 2019-nCoV has 40% identity with other SARS-related viruses, which is lower than",
      "retrieved_chunks": [
        "Unlike 2019-nCoV and human SARS-CoV, most known bat SARSr-CoVs have two stretches of deletions in the spike receptor binding domain when compared with that of human SARS-CoV.",
        "We found that the S2 subunit of 2019-nCoV is highly conserved and shares 99% identity with those of the two bat SARS-like CoVs and human SARS-CoV .",
        "The SL1, SL2, SL3, SL4, S5, SL5A, SL5B, and SL5C structures were similar among the 2019-nCoV, human SARS-CoV and the bat SARS-related ZC45. In the 2019-nCoV, part of the S5 found was inside Figure 7 Continued the orf1a/b , which was similar to SARS-CoV. In bat SARS-related CoV ZC45, the S5 was not found inside orf1a/b.",
        "However, the external subdomain of Spike\u2019s receptor binding domain of 2019-nCoV shares only 40% amino acid identity with other SARS-related coronaviruses.",
        "The 2019-nCoV had the same SL6, SL7, and SL8 as SARS-CoV, and an additional"
      ],
      "computed_relevance": 0.2857142857142857,
      "computed_utilization": 0.2857142857142857,
      "computed_completeness": 1.0,
      "computed_adherence": 0.0,
      "gt_relevance": 0.12,
      "gt_utilization": 0.04,
      "gt_completeness": 0.3333333333333333,
      "gt_adherence": 1.0,
      "binary_pred": 0,
      "binary_gt": 1,
      "is_valid": true,
      "is_rate_limited": false,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 4,
      "dataset_id": "669",
      "question": "What is Bacillus subtilis?",
      "ground_truth_answer": "Bacillus subtilis is a species of bacteria that has been shown to be effective in the prevention and/or treatment of intestinal diseases such as diarrhea, colitis, irritable bowel syndrome, irritable bowel disease, and colorectal cancer. It is also a part of the normal intestinal microbiome and has been found in the healthy human gastrointestinal tract. Bacillus subtilis produces surfactins, fengycins, and iturins, which have antimicrobial and antiviral properties.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking, \"What is Bacillus subtilis?\" and I need to answer based on the provided context.\n\nFirst, I'll look through the given passages. The first context mentions that Bacillus subtilis produces surfactins, fengycins, and iturins in a specific ratio. The other passages talk about Bacillus species in general, their use in probiotics, and their presence in fermented foods. \n\nThe main points I can gather are that B. subtilis is part of the Bacillus genus, which is used in probiotics and traditional fermented foods. It's noted for producing certain compounds (surfactins, fengycins, iturins) which might be part of its role in the intestinal microbiome. The passages also mention that Bacillus species were not traditionally considered part of the normal intestinal microbiome like Lactobacillus, but they are used in various probiotic products.\n\nI should make sure to mention its role in producing those specific lipopeptides, its use in probiotics, and maybe its application in food industry. Also, note that it's a spore-forming bacterium since the third passage mentions sporulation of B. subtilis. \n\nWait, the user's answer should be concise. Let me structure it: start with what it is (a species of Bacillus), mention the compounds it produces, its role in probiotics and food, and maybe its spore-forming ability. Check if all info is from the context provided. The context doesn't mention specific functions beyond what's in the passages, so avoid adding external knowledge. \n\nYes, the answer should combine the production of those three lipopeptides, its use in probiotics, and its presence in fermented foods. Also, note that it's part of the Bacillus genus which is used in various commercial probiotics. Make sure the answer is clear and directly answers the question using the given context.\n</think>\n\nBacillus subtilis is a species of the Bacillus genus, known for producing bioactive lipopeptides such as surfactins, fengycins, and iturins (in a ratio of 6:37:57). It is utilized in probiotics and traditional fermented foods due to its beneficial properties for intestinal health. While historically not classified as part of the normal intestinal microbiome, B. subtilis is recognized for its",
      "retrieved_chunks": [
        "Bacillus spp.",
        "subtilis produces surfactins, fengycins and iturins in a ratio of 6:37:57 .",
        "subtilis plays a\n\nTitle: Secretome of Intestinal Bacilli: A Natural Guard against Pathologies\nPassage: Historically, species of Lactobacillus and Bacillus are found in the traditional fermented food products possessing beneficial properties for the intestinal function and are widely used as components of commercially available probiotics: DE111 , Enterogermina , Biosubtyl , Biosporin , BioSpora , Blicheni and Zhengchangsheng , GanedenBC 30 , Lactobacterin , HOWARU or DR20 , Yakult , PCC . In food industry, lactobacilli are applied as starter cultures in the production of fermented milk products, cheese, sausages, bread, kimchi, pickles, and yogurts, the latter accounting for the largest share of sales . The administration of probiotics has been shown to favorably\n\nTitle: Secretome of Intestinal Bacilli: A Natural Guard against Pathologies\nPassage: For a long time, the representatives of Bacillus genus, unlike the species of Lactobacillus, were not considered as a part of the normal intestinal microbiome. Being isolated from feces, Bacillus spp.",
        "In environment, the vegetative forms of Bacillus are present usually near decomposing plants and in their\n\nTitle: Secretome of Intestinal Bacilli: A Natural Guard against Pathologies\nPassage: B.",
        "Sporulation of B."
      ],
      "computed_relevance": 0.25,
      "computed_utilization": 0.5,
      "computed_completeness": 1.0,
      "computed_adherence": 0.0,
      "gt_relevance": 0.4090909090909091,
      "gt_utilization": 0.18181818181818182,
      "gt_completeness": 0.3333333333333333,
      "gt_adherence": 0.0,
      "binary_pred": 0,
      "binary_gt": 0,
      "is_valid": true,
      "is_rate_limited": false,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 5,
      "dataset_id": "81",
      "question": "What past research has been done on severe, single-wave pandemics?",
      "ground_truth_answer": "The given passages do not specifically mention past research on severe, single-wave pandemics. However, they do reference research on pandemic strains, influenza spread, and pandemic severity categories, as well as the origins and circulation of specific pandemic influenza strains.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking about past research on severe, single-wave pandemics. I need to look through the provided contexts to find relevant information.\n\nFirst, looking at the first context titled \"The origins of the great pandemic,\" it mentions the 1889 pandemic with three major waves from 1889 to 1892, specifically noting the 1892 wave as the most intense. The passage also speculates about herald waves of the 1918 pandemic possibly starting as early as 1915. However, the 1889 example isn't a single wave but multiple. The 1918 pandemic is typically known for multiple waves as well, so maybe this isn't the best example for single-wave.\n\nNext, the second context about the 2009 pandemic in Hong Kong discusses research on pH1N1, including convalescent plasma treatment and studies on origins and pathogenesis. The 2009 pandemic had multiple waves in some regions, but the context doesn't specify if it's a single wave. However, the focus here is more on research responses rather than the pandemic's wave structure.\n\nThe third context is an economic analysis considering five pandemic severity categories and various interventions. It references previous studies using simulation models but doesn't mention single-wave pandemics specifically. The focus is on mitigation strategies and severity gradations, not the number of waves.\n\nThe fourth context from Taiwan discusses the 2009 pH1N1 pandemic and uses a Richards model variation to analyze multi-wave epidemics. It explicitly mentions multi-wave scenarios, so this isn't about single-wave.\n\nNone of the contexts directly mention research on single-wave pandemics. The examples given (1889, 1918, 2009) are all multi-wave. However, the first context does talk about considering herald waves extending back to 1915 for the 1918 pandemic, which might imply some research into earlier waves. But since the user is asking about severe, single-wave pandemics, and the provided contexts don't provide examples of such, I need to infer based on the information given.\n\nWait, maybe the answer is that the research mentioned in the contexts doesn't focus on single-wave pandemics. The 1889 example had three waves, 1918 had multiple, 200",
      "retrieved_chunks": [
        "Title: The origins of the great pandemic\nPassage: Because the 1889 pandemic unfolded with three major waves worldwide from 1889 to 1892 , with the 1892 wave being the most intense, at least on the East Coast of the USA, it seems worth considering whether so-called herald waves of the 1918 pandemic might have stretched back all the way to 1915. Viruses with identical or nearly identical genome sequences to those in the fall wave were circulating in early 1918 , at a time prior to the recognition of a new pandemic. It is perhaps not so great a leap to imagine that these viruses were related to\n\nTitle: The epidemiological and public health research response to 2009 pandemic influenza A(H1N1): experiences from Hong Kong\nPassage: of convalescent plasma to treat severe infections was shown to be feasible in a pandemic 57 and evidence of its effectiveness albeit from a small study should justify further studies.",
        "56 While we focused on research into the epidemiology, impact, and control of pH1N1, much important research on pH1N1 has been carried out in other areas outside the scope of our review.",
        "To give two specific examples, local researchers confirmed the origins of the 2009 pandemic strain by comparison with a detailed local swine influenza surveillance program, 65 and performed important basic studies on pathogenesis. 66 Two sets of studies\n\nTitle: Economic analysis of pandemic influenza mitigation strategies for five pandemic severity categories\nPassage: Several related studies which also used individualbased simulation models of influenza spread coupled with costing models are those of those of Sander et al., Perlroth et al., Brown et al., and Andradottir et al.",
        "The current study extends upon the scope of these studies in several ways: five gradations of pandemic severity are considered, more combinations of interventions are considered, social distancing interventions of varying durations are considered, and probabilities of severe health outcomes for each severity category are based on fatality, hospitalization and ICU usage data as observed from the 2009 pandemic.",
        "Also in contrast with those models,\n\nTitle: On Temporal Patterns and Circulation of Influenza Virus Strains in Taiwan, 2008-2014: Implications of 2009 pH1N1 Pandemic\nPassage: When there is more than one wave of infections, as in our current study, a variation of the Richards model can be utilized, which makes the distinction between two types of turning points ; one type which occurs at the peak incidence, and a second type which occurs in a multi-wave epidemic when the growth rate of the cumulative case number begins to increase again, indicating the beginning of the next wave."
      ],
      "computed_relevance": 0.25,
      "computed_utilization": 0.25,
      "computed_completeness": 1.0,
      "computed_adherence": 0.0,
      "gt_relevance": 0.26666666666666666,
      "gt_utilization": 0.26666666666666666,
      "gt_completeness": 1.0,
      "gt_adherence": 1.0,
      "binary_pred": 0,
      "binary_gt": 1,
      "is_valid": true,
      "is_rate_limited": false,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 6,
      "dataset_id": "1564",
      "question": "How many reported viral pneumonia?",
      "ground_truth_answer": "The passage does not provide a specific number of reported viral pneumonia cases overall. However, it mentions 2744 confirmed cases of pneumonia with 2019-nCoV infection in China, and it also mentions 77 fatal cases of pandemic H1N1v 2009 infection.",
      "generated_response": "<think>\nOkay, let's try to figure out how many reported viral pneumonia cases there are based on the given context. The user is asking for the number of reported cases, so I need to look through each of the provided passages to find any mention of numbers related to viral pneumonia.\n\nFirst, looking at the first passage: It talks about influenza attack rates during seasonal epidemics being between 10% and 20%, and higher during pandemics. The example given is the 2009 H1N1 pandemic in La Gloria, Veracruz, with clinical attack rates of 29% in adults over 15 and 61% in children under 15. However, these are attack rates, not actual numbers of cases. There's no specific number of cases reported here.\n\nNext, the second passage mentions bacterial co-infection in the 2009 H1N1 pandemic, analyzing 77 fatal cases. But again, this is about co-infections in fatal cases, not the total number of viral pneumonia cases.\n\nThe third passage is about pneumonia in adults hospitalized with seasonal influenza in the US from 2005\u20132008. It states that patients with pneumonia were more likely to receive antiviral therapy. However, there's no specific number given for the total cases of viral pneumonia here either.\n\nThe fourth passage is about 2019-nCoV (COVID-19) pneumonia. It mentions that by January 26, 2020, China had recorded 2744 confirmed cases of pneumonia with 2019-nCoV infection. This is a specific number, but it's about a different virus (SARS-CoV-2 causing COVID-19) and not influenza. The question is about viral pneumonia in general, but the context provided includes different viruses. However, the user's question is \"How many reported viral pneumonia?\" without specifying which virus. But the answer might need to consider all mentioned viruses. However, the first three passages are about influenza, and the last is about 2019-nCoV.\n\nWait, the user's question is about \"viral pneumonia\" in general. The context includes different viruses. The first three passages discuss influenza-related pneumonia, and the last one is about 2019-nCoV. The only specific number given is the 2744 cases of 2",
      "retrieved_chunks": [
        "Title: Clinical review: Primary influenza viral pneumonia\nPassage: age versus 6% to 9% of the adults 18 to 64 years of age and none of the children . Influenza attack rates during seasonal epidemics vary between 10% and 20% but can be much higher during pandemics. For example, an analysis of the pandemic 2009 H1N1 influenza A outbreak in La Gloria, Veracruz, found clinical attack rates of 29% in adults older than 15 years and 61% in children younger than 15 years of age .",
        "A total of confirmed cases were reported from Hong Kong, Macao and Taiwan of China:\n\nTitle: Clinical review: Primary influenza viral pneumonia\nPassage: Bacterial co-infection, though uncommonly reported in the early stages of the 2009 H1N1 pandemic, may be more prevalent than initially thought. A recent analysis of lung specimens from 77 fatal cases of pandemic H1N1v 2009 infection found a prevalence of concurrent bacterial pneumonia in 29% of these patients .",
        "Title: Pneumonia among adults hospitalized with laboratory-confirmed seasonal influenza virus infection\u2014United States, 2005\u20132008\nPassage: Patients with pneumonia ] were significantly more likely to receive influenza antiviral therapy than patients without pneumonia ; P <0.01].",
        "The most common coinfecting bacterial pathogens were pneumococcus, Staphylococcus aureus, and Streptococcus pyogenes, with a median duration of illness of 6 days .",
        "Title: A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version)\nPassage: At 24:00 on 26 January 2020, the National Health Commission of the People's Republic of China has recorded a total of 2744 confirmed cases of pneumonia with 2019-nCoV infection from 30 provinces , including 461 severe cases and 80 deaths."
      ],
      "computed_relevance": 0.375,
      "computed_utilization": 0.625,
      "computed_completeness": 1.0,
      "computed_adherence": 0.0,
      "gt_relevance": 0.125,
      "gt_utilization": 0.125,
      "gt_completeness": 1.0,
      "gt_adherence": 1.0,
      "binary_pred": 0,
      "binary_gt": 1,
      "is_valid": true,
      "is_rate_limited": false,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 7,
      "dataset_id": "1247",
      "question": "How has most of the analysis of MERS-CoV genetics  been performed?",
      "ground_truth_answer": "Most of the analysis of MERS-CoV genetics has been performed using high throughput or \"deep\" sequencing methods for complete genome deduction.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking how most of the analysis of MERS-CoV genetics has been performed. I need to look through the provided context to find the answer.\n\nLooking at the first passage, it starts with \"Most of the analysis of MERS-CoV genetics has been performed using high throughput or 'deep' sequencing methods for complete genome deduction.\" That seems like the direct answer. The passage also mentions that MERS-CoV was the first to have such widespread use of deep sequencing for studying an emerging viral outbreak globally.\n\nI should check the other passages to see if there's any conflicting information. The second passage talks about single nucleotide differences and specific regions of the genome, but doesn't mention the method used. The third passage mentions whole genome sequencing being used extensively, but that's in addition to the deep sequencing mentioned earlier. The fourth passage discusses genetic recombination and lineage differences but again doesn't contradict the first point.\n\nSo the main method is high throughput or deep sequencing for complete genome deduction. The answer should reflect that. I need to make sure to paraphrase correctly and cite the context accurately.\n</think>\n\nMost of the analysis of MERS-CoV genetics has been conducted using **high throughput or \"deep\" sequencing methods** for complete genome deduction. This approach was notably applied to study the virus's emergence and global spread, marking MERS-CoV as the first subject of such extensive deep sequencing during an emerging viral outbreak.",
      "retrieved_chunks": [
        "Title: MERS coronavirus: diagnostics, epidemiology and transmission\nPassage: Most of the analysis of MERS-CoV genetics has been performed using high throughput or \"deep\" sequencing methods for complete genome deduction . MERS-CoV was the first subject of such widespread use of deep sequencing to study an emerging viral outbreak with global reach.",
        "Despite assays having been published early on, subgenomic sequencing, once the mainstay of viral outbreak studies, has less often been published during MERS-CoV\n\nTitle: MERS coronavirus: diagnostics, epidemiology and transmission\nPassage: Analyses of MERS-CoV genomes have shown that most single nucleotide differences among variants were located in the last third of the genome , which encodes the spike protein and accessory proteins . At least nine MERS-CoV genomes contained amino acid substitutions in the receptor binding domain of the spike protein and codons 158 , 460 , 1020 , 1202 and 1208 bear investigation as markers of adaptive change . The spike protein had not changed in the recombinant MERS-CoV genome identified in China in 2015 but was reported to have varied at a higher rate than that for complete MERS-CoV\n\nTitle: MERS coronavirus: diagnostics, epidemiology and transmission\nPassage: Vigilance remains important for containment since MERS-CoV is a virus with a genetic makeup that has been observed for only three years and is not stable.",
        "Whole genome sequencing has been used extensively to study MERS-CoV travel and variation and although it remains a tool for experts, it appears\n\nTitle: MERS coronavirus: diagnostics, epidemiology and transmission\nPassage: Two studies during 2015, one looking at Jeddah-2014 MERS-CoV variants and another looking at a variant exported from South Korea to China, have now identified signs of genetic recombination among MERS-CoV variants.",
        "Among all humans reported to be infected, nearly 40 % have died.",
        "While human and camel whole genome sequences have retained >99 % identity with each other, members of genetically distinct lineages can and do swap genetic material when suitable conditions and coinfections co-occur ."
      ],
      "computed_relevance": 0.25,
      "computed_utilization": 0.25,
      "computed_completeness": 1.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.2857142857142857,
      "gt_utilization": 0.047619047619047616,
      "gt_completeness": 0.16666666666666666,
      "gt_adherence": 1.0,
      "binary_pred": 1,
      "binary_gt": 1,
      "is_valid": true,
      "is_rate_limited": false,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 8,
      "dataset_id": "1129",
      "question": "How were  the spread of GFP-expressing virus-infected cells tracked?",
      "ground_truth_answer": "The spread of GFP-expressing virus-infected cells was tracked using immunofluorescence microscopy, whole-organ imaging with IVIS, flow cytometry, and inverted fluorescence microscopy.",
      "generated_response": "<think>\nOkay, let's see. The question is asking how the spread of GFP-expressing virus-infected cells was tracked. I need to look through the provided context to find the methods mentioned.\n\nFirst, the context mentions that GFP expression was monitored during passaging using immunofluorescence microscopy with a GFP antibody. That's one method. Then, in the passage, they talk about using an inverted fluorescence microscope to monitor plates after applying an overlay until they saw the first signs of GFP expression. So that's another part of tracking.\n\nAlso, when generating single-cell clones, they used puromycin to select for GFP-expressing cells and then used limiting dilution. But maybe that's more about creating the clones rather than tracking spread. \n\nThe authors observed that after infection, certain percentages of dendritic cells, macrophages, and neutrophils expressed GFP. They probably used some kind of imaging or microscopy for that. The context also mentions that images were produced showing GFP cells in white and non-expressing in black, which would be through fluorescence microscopy. \n\nPutting it all together, the main methods seem to be immunofluorescence microscopy and fluorescence microscopy in general. The inverted fluorescence microscope is specifically mentioned for monitoring plates over time. So the answer would involve these techniques. They tracked the spread by observing the GFP expression under these microscopes, possibly taking images periodically to see how the infection spread through the cell cultures.\n</think>\n\nThe spread of GFP-expressing virus-infected cells was tracked using **fluorescence microscopy** and **immunofluorescence microscopy**. Specifically:  \n1. **Inverted fluorescence microscopy** was used to monitor plates periodically after applying an overlay until the first signs of GFP expression were observed.  \n2. **Immunofluorescence microscopy** with a GFP antibody was employed during passaging to visualize GFP-expressing cells (appearing white) against a black background of non-expressing cells.  \n3. Images were captured to document the progression of GFP expression in cell cultures, enabling quantification of infected cell populations (e.g., dendritic cells, macrophages, neutrophils) over time.  \n\nThis approach allowed the authors to observe and analyze the dynamics of viral spread in real time.",
      "retrieved_chunks": [
        "Expression of GFP was monitored during passaging by immunofluorescence microscopy using the GFP antibody.",
        "One color channel was imaged, such that images produced show GFP-expressing cells in white and non-GFP-expressing cells in black .",
        "Title: Accelerated viral dynamics in bat cell lines, with implications for zoonotic emergence\nPassage: After application of the overlay, plates were monitored periodically using an inverted fluorescence microscope until the first signs of GFP expression were witnessed .",
        "For the generation of single-cell clones stably expressing GFP, BGM and HeLa cells were transduced and grown in the presence of puromycin to generate pools of GFP-expressing cells, which were subsequently used to prepare single-cell clones by limiting dilution.",
        "The authors found that using a 10 6 PFU intranasal inoculation, 10% of dendritic cells were observed to express GFP and 2%-3% of macrophages and neutrophils were also GFP+ at 48 h post-infection ."
      ],
      "computed_relevance": 0.6,
      "computed_utilization": 0.4,
      "computed_completeness": 0.6666666666666666,
      "computed_adherence": 1.0,
      "gt_relevance": 0.21052631578947367,
      "gt_utilization": 0.21052631578947367,
      "gt_completeness": 1.0,
      "gt_adherence": 1.0,
      "binary_pred": 1,
      "binary_gt": 1,
      "is_valid": true,
      "is_rate_limited": false,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 9,
      "dataset_id": "1261",
      "question": "What's the recommended procedure to disinfect at CT scanner after a COVID-19 exposure?",
      "ground_truth_answer": "The recommended procedure to disinfect a CT scanner after a COVID-19 exposure involves sterilization procedures, noncontaminated CT disinfection procedures, and immediate disinfection of the imaging equipment after the examination.",
      "generated_response": "<think>\nOkay, let's see. The user is asking about the recommended procedure to disinfect a CT scanner after a COVID-19 exposure. The context provided has several passages with titles and passages mentioning CT disinfection procedures, fever-CTs, sterilization, and preparing to disinfect imaging equipment immediately after examination.\n\nFirst, I need to parse the context. The main points seem to be about emergency management related to COVID-19, specifically focusing on disinfection procedures for CT scanners. The key terms here are \"noncontaminated CT disinfection procedures,\" \"fever-CT disinfection,\" and \"imaging equipment prepared to disinfect immediately after examination.\"\n\nThe user wants to know the recommended steps. The context doesn't provide detailed steps, but it does mention that disinfection should happen immediately after the examination. Also, the terms \"sterilization procedures\" are used. Since the context is repetitive and mentions fever-CTs, maybe there's a specific protocol for those. However, the exact steps aren't detailed here. The answer should probably summarize the key points from the context: immediate disinfection after use, using proper sterilization methods, and possibly specific attention to fever-CTs. But since the context is a bit fragmented, I need to make sure not to add information beyond what's provided. The answer should be concise, based on the given context, and highlight the immediate disinfection after examination as the main procedure.\n</think>\n\nThe recommended procedure to disinfect a CT scanner after a suspected COVID-19 case involves **immediately disinfecting the imaging equipment post-examination** using established sterilization protocols. The context emphasizes prompt action to ensure noncontaminated CT or fever-CT scanners are properly disinfected after each use, particularly highlighting the need for emergency management in such scenarios. Specific steps (e.g., cleaning agents, contact time) are not detailed in the provided passages, but the key principle is **rapid disinfection to prevent cross-contamination**.",
      "retrieved_chunks": [
        "Title: The Battle Against Coronavirus Disease 2019 (COVID-19): Emergency Management\nPassage: Noncontaminated CT disinfection procedures after suspected COVID-19 case examination\n\nTitle: The Battle Against Coronavirus Disease 2019 (COVID-19): Emergency Management\nPassage: Fever-CT disinfection procedures after examination\n\nTitle: The Battle Against Coronavirus Disease 2019 (COVID-19): Emergency Management\nPassage: fever-CTs) after these sterilization procedures. Title: The Battle Against Coronavirus Disease 2019 (COVID-19): Emergency Management\nPassage: equipment and prepares to disinfect the imaging equipment immediately after the examination."
      ],
      "computed_relevance": 1.0,
      "computed_utilization": 1.0,
      "computed_completeness": 1.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.5,
      "gt_utilization": 0.5,
      "gt_completeness": 1.0,
      "gt_adherence": 1.0,
      "binary_pred": 1,
      "binary_gt": 1,
      "is_valid": true,
      "is_rate_limited": false,
      "is_skipped": false,
      "error": ""
    }
  ],
  "skipped_samples": []
}